IBB News Alert Nasdaq Biotechnology Ishares (IBB) 293.34 11/05/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 293.34 $IBB

Vote Cannabis? Marijuana Gains Political Traction on the Ballot
at The Street - Tue Nov 04, 4:04PM CST
Amid the array of issues taking center stage in today's midterm elections, cannabis referenda appear on the ballot in Florida, Oregon, Alaska and Washington, D.C.
GWPH: 73.32 (-0.79), XBI: 170.08 (-1.45), IBB: 293.34 (-2.97)

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.21% Yesterday
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 293.34 (-2.97)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.21% Gain
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 293.34 (-2.97)

After Yesterday's Rally of 2.66% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Oct 23, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 293.34 (-2.97)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.66% Gain
Comtex SmarTrend(R) - Thu Oct 23, 4:12PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 293.34 (-2.97)

Are Blue-Chip Stocks Past Their Prime or Still Worth Owning?
at The Street - Thu Oct 23, 3:15PM CDT
The 'Fast Money' trading panel looks at which blue-chip stocks investors should own, as well as at the overall stock market.
MMM: 155.05 (+1.75), GE: 25.70 (unch), HON: 95.29 (-0.37), NKE: 93.95 (+0.50), PRU: 88.04 (+0.16), UTX: 106.88 (+0.58), XBI: 170.08 (-1.45), SKX: 55.10 (-0.41), IBB: 293.34 (-2.97), KKR: 21.25 (+0.03), INTC: 34.54 (+0.23), UPS: 107.08 (+1.44), SPY: 201.07 (-0.70), IBM: 162.65 (-1.71), DIA: 173.46 (+0.10), DAN: 19.93 (-0.27), CAT: 98.61 (-1.61), MSFT: 47.57 (+0.13), KO: 41.82 (+0.01), IR: 61.34 (-0.47), DIS: 90.35 (-1.36), CLF: 11.33 (+0.35), WLT: 2.52 (+0.02), UA: 64.79 (-1.20), FTNT: 26.42 (+0.10)

3 Stocks I'll Buy if the Market Crashes
George Budwell, The Motley Fool - Motley Fool - Mon Oct 20, 12:01PM CDT
After a monstrous bull run of late, the stock market finally started to pullback. The Nasdaq Biotechnology Index , for instance, fell by nearly 7% last week alone: Even so, it's important to keep the magnitude of this week's drop in...
ACAD: 27.66 (-0.24), GILD: 109.72 (-0.26), SHPG: 195.62 (-0.87), NPSP: 27.18 (-0.11), IBB: 293.34 (-2.97), ABBV: 62.66 (-0.59)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.68% Rise
Comtex SmarTrend(R) - Fri Oct 17, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $263.11 to a high of $268.03. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $264.14 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 293.34 (-2.97)

IBB, GULF, GDP, DBOEY, Added To Naked Short Lists Today
M2 - Mon Oct 13, 10:51AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), WisdomTree Middle East Dividend Fund (NASDAQ:GULF), Goodrich Petroleum Corp (NYSE:GDP), Deutsche Boerse AG (OTC BOEY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
GDP: 7.29 (-0.37), GULF: 23.27 (+0.06), IBB: 293.34 (-2.97)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.09%
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 293.34 (-2.97)

After Yesterday's Decline of 2.09%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 293.34 (-2.97)

'Fast Money' Recap: Relief About the Stock Market Rally
at The Street - Thu Oct 09, 4:00AM CDT
The trading panel discussed where they are putting their money after the change in market direction.
F: 13.95 (-0.04), LMT: 190.79 (+0.04), ARWR: 6.41 (-0.11), XOP: 57.12 (-2.46), XBI: 170.08 (-1.45), C: 53.19 (-0.28), M: 56.30 (-0.95), IBB: 293.34 (-2.97), SHLD: 35.83 (+2.58), AA: 16.56 (-0.37), TJX: 63.86 (-0.04), RIG: 27.35 (-1.52), GILD: 109.72 (-0.26), GLD: 112.22 (+0.07), TGT: 61.37 (-0.22), JCP: 7.32 (-0.24), GM: 30.82 (-0.36), GOOGL: 564.19 (+0.42), GPS: 37.32 (-0.35), TWTR: 40.90 (+0.69), XLE: 84.27 (-1.77)

'Fast Money' Recap: What Should You Buy in a Declining Market?
at The Street - Wed Oct 08, 4:00AM CDT
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
PEI: 21.56 (-0.03), CLR: 51.53 (-4.20), GMCR: 152.11 (+0.21), TKMR: 16.25 (+0.26), IBB: 293.34 (-2.97), M: 56.30 (-0.95), JBLU: 12.14 (+0.40), UPS: 107.08 (+1.44), PEP: 96.73 (+0.90), SBUX: 76.71 (+0.61), AGN: 195.12 (+1.98), SAVE: 76.62 (+2.12), CMRX: 31.48 (+0.07), EOG: 90.28 (-3.04), DPZ: 90.25 (+0.70), COST: 136.55 (+2.28), GOOGL: 564.19 (+0.42), CMLS: 3.44 (-0.23), AAPL: 108.60 (-0.80), MBLY: 49.52 (-0.51), YUM: 72.06 (+0.50), APC: 89.12 (-1.62), AMBA: 45.48 (-2.08), AEC: 19.66 (-0.11), GPRO: 82.27 (-2.05), ETN: 67.91 (-0.52), IR: 61.34 (-0.47), GSK: 45.56 (+0.07), PXD: 180.91 (-7.23), MCD: 94.47 (+0.86), GM: 30.82 (-0.36), IWM: 115.82 (-0.54), SODA: 21.95 (-0.07)

Why Is George Soros Buying Celgene Corporation?
George Budwell, The Motley Fool - Motley Fool - Mon Oct 06, 9:01AM CDT
Superinvestors have transcended the investing landscape for one simple reason: they are awfully good at making money. Many smaller investors therefore like to track the movements of these "elephants" to see what they are buying and selling in hopes...
IBB: 293.34 (-2.97), CELG: 105.75 (-1.66)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 49.03 (-0.64), FBT: 98.69 (-1.01), XBI: 170.08 (-1.45), BBH: 115.11 (-1.11), IBB: 293.34 (-2.97)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.50% Loss
Comtex SmarTrend(R) - Wed Oct 01, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $267.58 to a high of $273.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $272.22 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 293.34 (-2.97)

'Fast Money' Recap: How to Trade After the Market's Drop
at The Street - Fri Sep 26, 4:00AM CDT
The trading panel likes the idea of buying Microsoft, Intel and other tech stocks if the market opens lower Friday
BIIB: 322.06 (+0.81), NKE: 93.95 (+0.50), XBI: 170.08 (-1.45), BBRY: 10.26 (+0.01), IBB: 293.34 (-2.97), INTC: 34.54 (+0.23), YHOO: 47.08 (+0.74), DD: 68.51 (-0.37), GOOGL: 564.19 (+0.42), MSFT: 47.57 (+0.13), AAPL: 108.60 (-0.80), REGN: 372.39 (-22.87), AMZN: 302.81 (-2.91), MU: 33.37 (-0.14), VRTX: 114.10 (+1.12), EMN: 80.52 (-1.51), FB: 75.76 (+1.88), BRCM: 41.55 (-0.25), PFE: 30.28 (+0.09), AMGN: 160.41 (-1.15), TIF: 94.34 (-2.00), HPQ: 35.90 (+0.04), PCLN: 1,097.70 (-100.82), LULU: 41.52 (-0.41), MHR: 4.17 (-0.25), GILD: 109.72 (-0.26), FNV: 46.27 (-2.00), RGLD: 59.39 (-1.90), IWM: 115.82 (-0.54), DOW: 47.58 (-1.55), BABA: 106.07 (+4.27), AN: 55.96 (-0.44)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 77

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Yum China Delivers Strong Q3 2026 Results Again

Updated Category News Views 70

A Steady March Forward for Yum China Yum China's third-quarter results reveal a company moving like a well-oiled machine, even in a turbulent market. A revenue uptick of 8% is no small feat, especially when operating under the weight of a 3% rise in system sales that neatly sidesteps the usual foreign exchange hiccups. This ain't just about keeping the lights on; it's...

Continue Reading
OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 35

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 46

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Tom Doyle Takes Helm at Gallagher's HR Consulting

Updated Category News Views 105

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Continue Reading
PASCO scientific Appoints David Lopez as New CEO

Updated Category News Views 70

New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...

Continue Reading
Graphic Packaging's Q3 2026 Results: Mixed Signals

Updated Category News Views 81

Graphic Packaging's Financial Figures: A Rough Ride Looking at the latest numbers from Graphic Packaging (NYSE: GPK), it's clear that the packaging landscape isn’t all wrapped up in a neat bow. Sure, the top line showed a slight uptick year-on-year with net sales nudging up $2 million to $2,192 million. Volumes were up too—by 1%—but that’s barely a blip when you...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 23

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Nucleus Reveals 2026 CPQ Value Chart for Manufacturers

Updated Category News Views 63

CPQ Tech: Unpacking the 2026 Manufacturing Landscape In the cutthroat world of manufacturing, it's adapt or die. Right now, happens it's the fixers in Configure, Price, Quote (CPQ) technology, stepping in to save the day. Nucleus Research just dropped their 2026 Manufacturing CPQ Technology Value Matrix, shining a bright spotlight on who’s leading the pack and why it...

Continue Reading

Top 5 Most Recently Viewed Articles

Imagine Pediatrics: Is Personalized Care the Game-Changer?

Updated Category News Views 181

February 18, 2026: Imagine Pediatrics rolled out a new white paper, unveiling how personalized pediatric care can dramatically improve outcomes for kids with special health care needs. The numbers? Striking. With over 8,350 'Safe Days at Home' logged and more than 5,000 emergency visits avoided, the message is clear—fragmented care is failing these vulnerable children....

Continue Reading
AWS and Oracle Forge New Partnership Amid Changing Landscape

Updated Category News Views 198

AWS and Oracle Team Up, Resetting a Long-Running Rivalry Amazon Web Services (AWS) and Oracle have struck a partnership that, not long ago, would’ve sounded far-fetched. The agreement lets customers run Oracle’s Autonomous Database and Exadata services directly within AWS. For teams already rooted in AWS, this reduces friction: data integration gets simpler, and...

Continue Reading
AMD Unveils Helios Platform for Advanced AI Infrastructure

Updated Category News Views 166

AMD Launches the Helios Rack-Scale Platform In a remarkable showcase at the Open Compute Project Global Summit, AMD introduced its innovative ‘Helios’ rack-scale design. This design represents a pioneering step forward in developing an open AI reference platform, strategically aligned with the newly established Open Rack Wide (ORW) standard contributed by Meta. By...

Continue Reading
Investors Gear Up for Axon Enterprise's Upcoming Earnings

Updated Category News Views 147

What to Expect from Axon Enterprise's Earnings Release Axon Enterprise (NASDAQ: AXON) is poised to share its quarterly earnings report soon, an event that always garners the attention of investors seeking insights into the company's performance. With anticipation building, let’s delve into what analysts are projecting and how these figures could influence market...

Continue Reading
Celebrating Exceptional Partnerships: Sherwin-Williams & Awards

Updated Category News Views 507

Honoring Excellence: Sherwin-Williams 2024 Awards Ceremony In a vibrant celebration of dedication and success, Sherwin-Williams recently announced its 2024 Vendor of the Year award winners during a prestigious event. This annual gathering not only reflects the company’s achievements but also pays tribute to the remarkable partners that contribute significantly to its...

Continue Reading